Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer.

Our study provides a strong basis for understanding the mechanisms by which proteasome inhibitors exert anticancer effects. We find open chromatin regions that change during proteasome inhibition, are typically accessible in non-basal breast cancers.